Autor: Firma Tentamus Group

Wintermeeting 2025: Gemeinsam kreativ – TentaConsult stärkt Teamgeist am Ammersee!

Fachwissen ist essenziell – doch erst ein eingespieltes Team macht exzellente Beratung möglich. Deshalb treffen sich die Teams der TentaConsult Pharma & Med GmbH einmal im Jahr zum Wintermeeting, um den interdisziplinären Austausch zu stärken und neue Impulse zu gewinnen. Dieses Jahr fand das Treffen erstmals am Ammersee im Haus der Bayerischen Landwirtschaft statt. Die […]

Read More

Tentamus Group welcomes Christopher Loke as Director of Strategic Marketing for Tentamus North America

. The Tentamus Group welcomes Christopher Loke as Director of Strategic Marketing for Tentamus North America. Chris brings a wealth of experience and expertise to this role, most recently from ARL- a Tentamus Company. His strong background in marketing, combined with his energy, skills, and knowledge, will be invaluable as we continue to grow and […]

Read More

Tentamus Group Welcomes Jacob Teller as Sr. Director of Quality & Accreditations for Tentamus North America

Jacob brings a wealth of knowledge, expertise, and a deep understanding of quality systems that will be instrumental in driving our continued success. He has been with ARL – a Tentamus Company for 17 years, holding several key positions including Lead Chemist, Quality Manager, and most recently, Quality Director. As Lead Chemist, Jacob developed advanced […]

Read More

QSI and WESSLING statement on the concretization of the Consumer Cannabis Act

Since 1 July 2024, the Consumer Cannabis Act (KCanG) has enabled the cultivation of cannabis in Cannabis Social Clubs. However, the current legal situation poses a number of challenges for those. QSI and WESSLING, both DAkkS-accredited and GMP-certified laboratories specializing in the analysis of industrial hemp and medicinal cannabis, have submitted a joint statement to […]

Read More

Stellungnahme QSI und WESSLING zur Konkretisierung des Konsumcannabisgesetzes

Seit dem 1. Juli 2024 ermöglicht das Konsumcannabisgesetz (KCanG) den Anbau von Cannabis in Anbauvereinigungen. Die aktuelle Gesetzeslage stellt die Vereine jedoch vor einige Herausforderungen. QSI und WESSLING, beides DAkkS-akkreditierte und GMP-zertifizierte Labore, die auf die Analyse von Nutzhanf und Medizinalcannabis spezialisiert sind, haben diesbezüglich eine gemeinsame Stellungnahme an das BMG (Bundesministerium für Gesundheit) und […]

Read More

Bilacon receives GAFTA certification – another milestone for quality and safety in food and feed analysis

We are pleased to announce that bilacon, a leading laboratory of the Tentamus Group, has successfully achieved GAFTA (Grain and Feed Trade Association) certification. This certification is a significant step that underlines our competence and commitment to the highest standards in the analysis of grain, feed and related products. GAFTA certification is an internationally recognized […]

Read More

Bilacon erhält GAFTA-Zertifizierung – Ein weiterer Meilenstein für Qualität und Sicherheit in der Lebens- und Futtermittelanalytik

Wir freuen uns, bekannt zu geben, dass bilacon, ein führendes Labor der Tentamus Group, erfolgreich die GAFTA-Zertifizierung (Grain and Feed Trade Association) erhalten hat. Diese Zertifizierung ist ein bedeutender Schritt, der unsere Kompetenz und unser Engagement für höchste Standards in der Analyse von Getreide, Futtermitteln und verwandten Produkten unterstreicht. Die GAFTA-Zertifizierung ist ein international anerkanntes […]

Read More

Tentamus Group reinforces its commitment to Central and Southern Italy

The Tentamus Group Italy announces the merger between MK’s headquarters in Città di Castello and Tentamus Agriparadigma, creating the latter’s fourth operational headquarters in the heart of Umbria. The operational headquarters will be up and running from February 2025 under the new name "Tentamus Agriparadigma". This represents a strategic step for the Group, aimed at […]

Read More

VelaLabs Announces Strategic Partnership with EarlyHealth Group to Support Biological Drugs Development

VelaLabs GmbH, a leading provider of analytical and quality services for biopharmaceutical development, has signed a Memorandum of Understanding (MoU) with EarlyHealth Group to establish comprehensive solutions for the development of advanced biological drugs. The partnership brings together the strengths of both companies in streamlining biological drug development and providing end-to-end support, from early product […]

Read More

Established Products and New Limits in Agrochemicals and Biocides

The global focus on green agrochemistry and the health of consumers and operators continues to grow, driving significant changes in the regulation of agrochemicals. Agrochemicals are increasingly subject to recertification as new regulations are introduced annually. Even long-established products must now provide updated impurity data, often with stricter limits than before. A notable example includes […]

Read More